Michigan Technology and Research Institute plans to hire

It didn’t scare Michael Bleavins when Pfizer pulled up stakes in Ann Arbor two years ago. It actually reaffirmed that he had made the right decision.The former Pfizer scientist was just starting the Michigan Technology and Research Institute with three of his colleagues when the news broke. Today their start-up is debuting new products, employs seven and could hire another 1-3 people this year.”We wanted to stay in the area,” Bleavins says. “It’s an area we believe in so we wanted to make a go of it.”The institute does laboratory work and drug-research consulting. Its latest offering is DNA testing for human clinical trials. It has signed two companies to contracts for its services and hopes to land another 3-4 more this year.That would allow the firm to at least hire one more researcher, if not more. A lot of these sorts of hires turn out to be old co-workers or friends that Bleavin and his co-founders want to work with for the foreseeable future, or at least until Pfizer comes back.Source: Michael Bleavins, co-founder of the Michigan Technology and Research InstituteWriter: Jon Zemke

It didn’t scare Michael Bleavins when Pfizer pulled up stakes in Ann Arbor two years ago. It actually reaffirmed that he had made the right decision.

The former Pfizer scientist was just starting the Michigan Technology and Research Institute with three of his colleagues when the news broke. Today their start-up is debuting new products, employs seven and could hire another 1-3 people this year.

“We wanted to stay in the area,” Bleavins says. “It’s an area we believe in so we wanted to make a go of it.”

The institute does laboratory work and drug-research consulting. Its latest offering is DNA testing for human clinical trials. It has signed two companies to contracts for its services and hopes to land another 3-4 more this year.

That would allow the firm to at least hire one more researcher, if not more. A lot of these sorts of hires turn out to be old co-workers or friends that Bleavin and his co-founders want to work with for the foreseeable future, or at least until Pfizer comes back.

Source: Michael Bleavins, co-founder of the Michigan Technology and Research Institute
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU
Ann Arbor Housing Commission

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.